BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25997320)

  • 1. Desensitization to lenograstim after a life- threatening reaction to filgrastim.
    Nuñez-Acevedo B; Rodríguez-Jiménez B; Domínguez-Ortega J; González-Montellano E; Ibáñez-Heras N; Enrech-Francés S
    J Investig Allergol Clin Immunol; 2015; 25(2):158-60. PubMed ID: 25997320
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels.
    Ojaimi S; Harnett PR; Fulcher DA
    J Allergy Clin Immunol Pract; 2014; 2(1):105-6. PubMed ID: 24565780
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A; Saito H; Toyama K; Horiuchi A; Kuriya S; Furusawa S; Tsuruoka N; Takiguchi T; Matsuda T; Utsumi M; Shiku H; Matsui T; Egami K; Tamura K; Ohno R
    Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [No cross hypersensitivity between molgramostim and filgrastime: apropos of a case].
    Chichmanian RM; Heudier P; Taillan B; Fuzibet JG
    Therapie; 1995; 50(5):478-9. PubMed ID: 8571295
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests.
    Berti A; Della-Torre E; Yacoub M; Tombetti E; Canti V; Sabbadini MG; Colombo G
    Eur Ann Allergy Clin Immunol; 2016 Jul; 48(4):137-44. PubMed ID: 27425169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children.
    Hong DI; Dioun AF
    J Allergy Clin Immunol Pract; 2014; 2(1):13-9; quiz 20. PubMed ID: 24565764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of severe reactions after iodinated contrast media injection: review of the literature].
    Dewachter P; Mouton-Faivre C
    J Radiol; 2003 May; 84(5):535-44. PubMed ID: 13677822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate hypersensitivity to human recombinant granulocyte-macrophage colony-stimulating factor associated with a positive prick skin test reaction.
    Engler RJ; Weiss RB
    Ann Allergy Asthma Immunol; 1996 Jun; 76(6):531-4. PubMed ID: 8673688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-interventional study for the treatment of neutropenia: Use of pegfilgrastim for chemotherapy-induced neutropenia].
    Wülfing C; Rexer H
    Urologe A; 2016 Jan; 55(1):76-7. PubMed ID: 26666910
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin desensitization in a patient with NSAID-induced delayed angioedema.
    Rijo Y; Canabal J; Fiandor A; Bobolea I; Quirce S; Cabañas R
    J Investig Allergol Clin Immunol; 2015; 25(2):156-8. PubMed ID: 25997319
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug eruption caused by recombinant human G-CSF.
    Sasaki O; Yokoyama A; Uemura S; Fujino S; Inoue Y; Kohno N; Hiwada K
    Intern Med; 1994 Oct; 33(10):641-3. PubMed ID: 7530069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose filgrastim therapy for chronic neutropenia.
    Kaczmarski RS; Mufti GJ
    N Engl J Med; 1993 Oct; 329(17):1280-1. PubMed ID: 7692296
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical use of granulocyte-colony stimulating factor.
    Shah J; Welsh SJ
    Br J Hosp Med (Lond); 2014 Feb; 75(2):C29-32. PubMed ID: 24521833
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective acute desensitization for immediate-type hypersensitivity to human granulocyte-monocyte colony stimulating factor.
    Shahar E; Krivoy N; Pollack S
    Ann Allergy Asthma Immunol; 1999 Dec; 83(6 Pt 1):543-6. PubMed ID: 10619347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immediate allergic reactions to cephalosporins in non-penicillin-allergic patients.
    Somech R; Weber EA; Lavi S
    Int Arch Allergy Immunol; 2009; 150(3):205-9. PubMed ID: 19494517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Hypersensitivity and Desensitizations.
    Castells MC
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):xvii-xviii. PubMed ID: 28965644
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management and choice of antibiotics for patients with an allergy to penicillin].
    Rijnders BJ; Ceuppens JL; Peetermans WE
    Ned Tijdschr Geneeskd; 1999 Feb; 143(7):336-41. PubMed ID: 10221094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to the patient with drug allergy.
    Schnyder B
    Med Clin North Am; 2010 Jul; 94(4):665-79, xv. PubMed ID: 20609856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.